Professional Medical Expertise Company (TADAWUL: 9574)
Saudi Arabia
· Delayed Price · Currency is SAR
89.00
-1.00 (-1.11%)
Dec 19, 2024, 2:51 PM AST
Professional Medical Expertise Company Cash Flow Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | 27.79 | 24.84 | 19.02 | 20.62 | 9.3 |
| Depreciation & Amortization | 6.18 | 5.45 | 3.07 | 2.37 | 1.92 |
| Loss (Gain) From Sale of Assets | -1.09 | -1.09 | -0 | 0.06 | 0.42 |
| Provision & Write-off of Bad Debts | 3.86 | 2.79 | 2.39 | 0.44 | 0.5 |
| Other Operating Activities | 12.03 | 7.99 | 6.23 | 4.2 | 1.79 |
| Change in Accounts Receivable | -29.82 | -37.55 | -14.57 | -33.12 | 7.81 |
| Change in Inventory | -33.42 | -40.43 | -25.19 | -13.39 | -10.44 |
| Change in Accounts Payable | 15.94 | 47.69 | 6.95 | 28.71 | -3.77 |
| Change in Other Net Operating Assets | 2.31 | -3.82 | -1.82 | 11.14 | 4.47 |
| Operating Cash Flow | 3.78 | 5.88 | -3.92 | 21.03 | 11.99 |
| Operating Cash Flow Growth | -69.50% | - | - | 75.31% | - |
| Capital Expenditures | -9.36 | -8.98 | -6.51 | -3.34 | -2.06 |
| Sale of Property, Plant & Equipment | 2.17 | 2.18 | 0.12 | - | - |
| Cash Acquisitions | - | - | - | - | -0.23 |
| Investing Cash Flow | -7.19 | -6.8 | -6.39 | -3.34 | -2.29 |
| Short-Term Debt Issued | - | 4.66 | 18.79 | 0.63 | 10.66 |
| Total Debt Issued | 30.48 | 4.66 | 18.79 | 0.63 | 10.66 |
| Long-Term Debt Repaid | - | -1.94 | -0.63 | -0.47 | -0.28 |
| Net Debt Issued (Repaid) | 27.72 | 2.72 | 18.16 | 0.16 | 10.38 |
| Issuance of Common Stock | - | - | - | - | 0.03 |
| Common Dividends Paid | -9.98 | - | -16 | -2.9 | -17.1 |
| Other Financing Activities | -8 | -6.16 | -4.33 | -2.52 | -1.28 |
| Financing Cash Flow | 9.75 | -3.44 | -2.17 | -5.26 | -7.98 |
| Miscellaneous Cash Flow Adjustments | - | - | - | - | 0.07 |
| Net Cash Flow | 6.33 | -4.36 | -12.49 | 12.43 | 1.79 |
| Free Cash Flow | -5.58 | -3.1 | -10.43 | 17.69 | 9.93 |
| Free Cash Flow Growth | - | - | - | 78.03% | - |
| Free Cash Flow Margin | -1.99% | -1.24% | -5.93% | 13.48% | 13.35% |
| Free Cash Flow Per Share | -1.59 | -0.89 | -4.67 | 22.93 | - |
| Cash Interest Paid | 8 | 6.16 | 4.33 | 2.52 | 1.28 |
| Levered Free Cash Flow | -28.71 | -13.2 | -48.33 | 9.68 | - |
| Unlevered Free Cash Flow | -27.52 | -13.2 | -48.33 | 9.68 | - |
| Change in Net Working Capital | 48.29 | 30.52 | 61.15 | 4.64 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.